Healthcare execs understand the need to provide personalized care to patients. That’s why nine out of 10 biopharma executives agree that their industry will unanimously convert to using AI-backed marketing tools to ensure relevant engagement and personalization to HCPs within the next 3-5 years.

Yet, while most pharma executives realize the utility of data and analytics, there are gaps that prevent them from making full use of this technology. For example, some of the main problems this technology aims to solve — and how it solves them — include:

• How do I collect data? It’s collected seamlessly across all channels with the speed and convenience of being entirely cloud native.
• What do I do with that data? Data is used to drive machine learning and deep learning leading to model deployment.
• How do I communicate with the HCP?  Digital decisioning provides personalized, actionable insights in real time for effective customer engagement.

​​